| FDA for emergency use authorization | Janssen COVID-19 vaccine: Fact sheet for recipients and caregivers |
|---|---|
| Centers for Disease Control and Prevention | Interim considerations for COVID-19 vaccination of healthcare personnel and long-term care facility residents |
| Janssen COVID-19 vaccine: Fact sheet for healthcare providers administering vaccine | Benefits of getting a COVID-19 vaccine |
|---|---|
| Moderna COVID-19 vaccine: Fact sheet for recipients and caregivers | Morbidity and Mortality Weekly Report |
Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States.
18| Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
|---|---|
| Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U | COVID-19 vaccines and allergic reactions |
FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine.
9